Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma

SIMPLE SUMMARY: Immunotherapy targeting the programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) has attracted worldwide attention and is setting off a revolution in cancer treatment, bringing new hope to cancer patients. PD-L2 is another ligand of PD-1 and a promising immunotherapy marker. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Yun-Yun, Shi, Yue, Gong, Xue-Qin, Li, Li, Li, Zu-Mao, Yang, Lin, Zhang, Xiao-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856314/
https://www.ncbi.nlm.nih.gov/pubmed/36672315
http://dx.doi.org/10.3390/cancers15020365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856314/
https://www.ncbi.nlm.nih.gov/pubmed/36672315
http://dx.doi.org/10.3390/cancers15020365

Ejemplares similares